Danville, CA, United States of America

Wei Xu

USPTO Granted Patents = 79 

 

 

Average Co-Inventor Count = 5.4

ph-index = 17

Forward Citations = 1,359(Granted Patents)

Forward Citations (Not Self Cited) = 1,326(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Richmond, CA (US) (1997 - 2004)
  • Houston, TX (US) (2001 - 2017)
  • Cypress, TX (US) (2016 - 2022)
  • Danville, CA (US) (2001 - 2023)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
79 patents (USPTO):

Title: The Innovative Mind of Wei Xu: A Pioneer in Kinase-Dependent Treatments

Introduction: Wei Xu, a notable inventor based in Danville, California, has made significant strides in the field of pharmaceutical innovations. With an impressive portfolio of 55 patents, his work focuses on developing compounds that target kinase-dependent disorders and adenosine receptors, showcasing his commitment to advancing medical science.

Latest Patents: Among Wei Xu's latest contributions to the field are two groundbreaking patents. The first patent involves "Compounds for the treatment of kinase-dependent disorders," which discloses compounds of Formula (I′) that inhibit, regulate, and/or modulate kinase receptor pathways, particularly Axl and Mer. This invention emphasizes methods for treating various kinase-dependent diseases and conditions, providing a new horizon for therapeutic interventions. The second patent addresses "Heterocyclic adenosine receptor antagonists," highlighting heterocyclic compounds useful as antagonists of adenosine receptors, along with pharmaceutical compositions and methods of administration.

Career Highlights: Wei Xu's career has seen him collaborate with esteemed companies, including Exelixis, Inc. and Schering Aktiengesellschaft. His extensive experience in these organizations underlines his expertise and significant contributions to the pharmaceutical industry, particularly in drug development and innovation.

Collaborations: Throughout his career, Wei Xu has worked alongside several notable colleagues, including Brad Owen Buckman and Michael M. Morrissey. These collaborations have undoubtedly enriched his research endeavors and led to impactful innovations in the realm of pharmaceuticals.

Conclusion: Wei Xu stands as an exemplary inventor whose work in kinase-dependent treatments and adenosine receptors continues to inspire medical advancements. With a robust patent portfolio and impressive collaborations, his contributions play a vital role in shaping the future of drug development and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…